Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling via growth factor secretion refers to a *cellular communication process* in which cells secrete growth factors, cytokines, or peptides into the local extracellular environment. These signaling molecules diffuse a short distance to neighboring cells, where they bind to specific cell surface receptors (commonly receptor tyrosine kinases) and activate signaling cascades that regulate cell behavior. Unlike endocrine signaling, which acts systemically, paracrine signaling is restricted to nearby cells. Major growth factors involved in paracrine signaling include fibroblast growth factor (FGF), transforming growth factor beta (TGF-β), vascular endothelial growth factor (VEGF), and others[1][5][6]. These pathways play critical roles in *development, tissue regeneration, wound healing, and disease processes such as cancer* through regulation of proliferation, differentiation, and survival of target cells[4][5][6]. The term does not refer to a single molecule or receptor, so it is not considered a canonical therapeutic target[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling via growth factor secretion.